0000950170-24-065545.txt : 20240528
0000950170-24-065545.hdr.sgml : 20240528
20240528195906
ACCESSION NUMBER: 0000950170-24-065545
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240523
FILED AS OF DATE: 20240528
DATE AS OF CHANGE: 20240528
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Soteropoulos Paula
CENTRAL INDEX KEY: 0001692444
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38541
FILM NUMBER: 24993671
MAIL ADDRESS:
STREET 1: 49 WINONA STREET
CITY: PEABODY
STATE: MA
ZIP: 01960
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dianthus Therapeutics, Inc. /DE/
CENTRAL INDEX KEY: 0001690585
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 TECHNOLOGY SQUARE
STREET 2: 8TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-201-2700
MAIL ADDRESS:
STREET 1: 300 TECHNOLOGY SQUARE
STREET 2: 8TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Magenta Therapeutics, Inc.
DATE OF NAME CHANGE: 20161121
4
1
ownership.xml
4
X0508
4
2024-05-23
0001690585
Dianthus Therapeutics, Inc. /DE/
DNTH
0001692444
Soteropoulos Paula
C/O DIANTHUS THERAPEUTICS, INC.
7 TIMES SQUARE, 43RD FLOOR
NEW YORK
NY
10036
true
false
false
false
false
Stock Option (Right to Buy)
21.77
2024-05-23
4
A
false
11000
0
A
2034-05-22
Common Stock
11000
11000
D
The shares of common stock underlying this stock option award will vest in full on the date that is the earlier of (i) the first anniversary of the grant date or (ii) the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer through the vesting date.
/s/ Adam Veness, as attorney-in-fact for Paula Soteropoulos
2024-05-28